Dutch Life Sciences &
Health Conference 2010
This page about last year’s Dutch Life Sciences & Health Conference may give you an impression of what the conference has to offer.
Impression
Click here for a photo impression of the Dutch Life Sciences & Health Conference 2010
Topics
- From innovation to commercialisation
- From innovation to litigation
- New ventures and emerging companies
Speakers
- T. van Aken, CEO Avantium
- R. Bergkamp, Ministry of Economic Affairs of the Netherlands,
- Director-General of Enterprise and Innovation
- J. Bird, Partner, Life Science Practice JLT-Group
- Dr. S. Braam, CSO Pluriomics
- R. Bulthuis, Head of Merck Serono Ventures Merck Serono SA
- N. Campbell, Partner and Head of Life Science Practice JLT-Group
- P. Gallen, former Risk Manager of Elan Safe Harbour
- T. Hanke Ph.D., Sourcing Director Novo Nordisk
- Dr. ir. C.G.P. Herben, Valorisation Manager Netherlands Genomics Initiative
- Dr. W.N.G.M. de Laat M.D., Ph.D., Managing Director Life Sciences & Health
- Prof. A. Osterhaus, Artemis
- Dr. O. Schoots MBA, Director UU Holding BV / UMC Utrecht Participaties
- Dr. M. van der Sluis, Manager Business Development Drug Development Cluster
- G. Staaf, CEO Avantium Pharmaceuticals United Kingdom
- Dr. M.A. Thompson Ph.D., VP Regulatory Affairs and Quality Assurance MDxHealth Inc.
- ir. J. Voorham, Founder MAXAM Medical
- M. de Weer, Sr. Dir. CM&C Development Galapagos
- Dr. H. Windels, CFO SEPS Pharma, CFO Pronota and
- board member MDxHealth and Flanders Vio DeVGen
- R.M. Wolf, Senior Director Venturing Philips Research
Participants
Over 300 participants
105 Dedicated Life Sciences Companies
110 Services, Consultancies, CMO & CRO
51 Research organisations, Academic Medical Centres & Universities
19 Investors
33 Governmental & Branch Organisations
Investors forum
Participating investors/funds:
2MEDICAL-europe
Aglaia Biomedical Ventures BV
Elixior Ltd
Forbion Capital Partners
Life Sciences & Health
Life Sciences Legal
LSP
Merck Serono Ventures
Rabobank IKT
Return On Science Ventures i.o.
RUG houdstermaatschappij BV
Thuja Capital Management
Utrecht Holdings
UVA
VenGen
Presenting companies:
Crossbeta Biosciences
Virtual Proteins
MSD
Syntecnos
OrgaNext Research BV
GlycoCheck
Trajectum Pharma B.V.
EmulTech BV
NightBalance
Tispa Medical BV
InGell Labs BV
Virtual Proteïns was awarded a prize consisting of professional advice that will further boost the development of the company, offered by Life Sciences Legal, Arnold & Siedsma, VenGen, PwC, La Lique, Swis, Szienz and Life Sciences & Health.
|
